期刊
NEUROPHARMACOLOGY
卷 68, 期 -, 页码 116-121出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2012.08.013
关键词
Adenosine; Anxiety; Autism; ATP; Ketogenic diet; Metabolism
资金
- National Institutes of Health from the National Institute of Neurological Disorders and Stroke (NINDS) [NS065957, NS066932]
- National Science Foundation [IOS-0843585]
- Division Of Integrative Organismal Systems
- Direct For Biological Sciences [843585] Funding Source: National Science Foundation
In rodents, insufficient adenosine produces behavioral and physiological symptoms consistent with several comorbidities of autism. In rodents and humans, stimuli postulated to increase adenosine can ameliorate these comorbidities. Because adenosine is a broad homeostatic regulator of cell function and nervous system activity, increasing adenosine's influence might be a new therapeutic target for autism with multiple beneficial effects. This article is part of the Special Issue entitled 'Neurodevelopmental Disorders'. (c) 2012 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据